eSight and CNIB Announce National Partnership to Benefit Canadians with Sight Loss

In honour of World Sight Day, eSight, a Canadian-based world leader in vision technology, announces a new partnership with CNIB. The partnership, the first of its kind for eSight, will expand access of its flagship product, eSight 3, to individuals living with sight loss in Canada. Recognized as a “Top Innovation” by Time Magazine, eSight 3 is an advanced assistive device that enables many individuals living with central vision loss to see more clearly.

“This partnership will make a significant difference in the lives and independence of many Canadians with sight loss,” said John M. Rafferty, President & CEO, CNIB Foundation. “With greater access to eSight, many individuals will have opportunities they never before thought possible – to see the faces of their loved ones, to return to work, to perform better in school, to rediscover hobbies and feel more confident in new environments.”

Starting October 10th, eSight 3 will be available for purchase at five CNIB locations in British Columbia, Ontario and Nova Scotia, together with training provided by both eSight and CNIB. The program will expand to CNIB locations across Canada in the following 12 months, providing greater ease of access and training support for low vision Canadians.

“CNIB was the obvious choice as our premier national distribution partner because we share a passion to change the lives of Canadians living with visual impairments,” said Sam Ifergan, Executive Chairman of eSight. “We’re proud to partner with CNIB as our premier retail and training destination where Canadians can experience the amazing benefits of eSight before they purchase.”

Click HERE for the full press release.

Featured Posts

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read More

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read More

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read More

Winners of the 30th SILMO d’Or

And here are the winners!

Read More

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more